ABBVIE INC. vs. Mirum Pharmaceuticals, Inc. Common Stock
ABBVIE INC. (ABBV) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| ABBV | MIRM | |
|---|---|---|
| Market Cap | $466.55 billion | $6.53 billion |
| Revenue (TTM) | $64.39 billion | $618.07 million |
| Net Income (TTM) | $6.32 billion | $-860,207,000 |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | MIRM | |
|---|---|---|
| P/E Ratio | 74.71 | — |
| Price / Book | -79.24 | -626.83 |
| Price / Sales | 7.25 | 10.57 |
ABBV and MIRM split the valuation factors evenly.
Profitability
| ABBV | MIRM | |
|---|---|---|
| Net Margin | 9.81% | -139.18% |
| Return on Equity | -107.29% | 8253.76% |
ABBV and MIRM split the profitability factors evenly.
Dividend
| ABBV | MIRM | |
|---|---|---|
| Dividend Yield | 2.62% | — |
| Payout Ratio | 195.48 | — |
ABBV and MIRM split the dividend factors evenly.
Risk & Sentiment
| ABBV | MIRM | |
|---|---|---|
| Short Interest | 0.85% | 0.09% |
MIRM leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, MIRM overview, MIRM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.